---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-070193"
form_type: "8-K"
ticker: "ATNM"
cik: "0001388320"
company_name: "Actinium Pharmaceuticals, Inc."
filed_at: "2026-06-18T21:00:24+00:00"
generated_at: "2026-06-18T21:04:26.755023+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Actinium submits NYSE American compliance plan after equity deficiency notice

## Summary
- Received NYSE American deficiency notice on May 27, 2026, for Section 1003(a)(ii): equity below required $4M.
- Submitted compliance plan on June 18, 2026, outlining intended actions to restore listing standards.
- No specific plan details disclosed; exchange will review plan during continued trading.
- Company faces potential delisting if plan not accepted or compliance not achieved within extension period.

## SEC filing metadata
- accession: 0001213900-26-070193
- form_type: 8-K
- ticker: ATNM
- cik: 0001388320
- company_name: Actinium Pharmaceuticals, Inc.
- filed_at: 2026-06-18T21:00:24+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1388320/000121390026070193/0001213900-26-070193-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1388320/000121390026070193/ea0295259-8k_actinium.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-070193
- JSON: https://secwatch.observer/filing/0001213900-26-070193.json
- Plain text: https://secwatch.observer/filing/0001213900-26-070193.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.